Developing LNP/mRNA Therapeutics to Achieve Antigen-Specific Immune Tolerance
Time: 8:00 am
day: Custom Day Two
Details:
• Highlighting the unique benefits of using a Multi-Cargo LNP approach to deliver autoantigens and modulate the immune system
• Discussing the biodistribution and mechanism of LNP/mRNA in inducing immune tolerance
• Showcasing the therapeutic potential of LNP/mRNA technology in type 1 diabetes and other autoimmune diseases
